Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Leukemia 54Myelodysplastic Syndromes 42Lymphoma, Non-Hodgkin 19Congenital Abnormalities 15Lymphoma 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Leukemia, Lymphocytic, Chronic, B-Cell 13Hodgkin Disease 13Recurrence 11Leukemia, Myelomonocytic, Chronic 11Leukemia, Myelomonocytic, Acute 10Leukemia, Monocytic, Acute 10Leukemia, Megakaryoblastic, Acute 10Leukemia, Erythroblastic, Acute 10Leukemia, Biphenotypic, Acute 9Neoplasms 8Hematologic Neoplasms 8Multiple Myeloma 7Burkitt Lymphoma 7Anemia, Refractory, with Excess of Blasts 7Leukemia, Myelomonocytic, Juvenile 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Promyelocytic, Acute 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Graft vs Host Disease 5Lymphoma, Mantle-Cell 4

Interventions

Cyclophosphamide 22blinatumomab 18Cytarabine 15fludarabine 13Azacitidine 12venetoclax 10fludarabine phosphate 10Rituximab 8Lenalidomide 7Dexamethasone 7Methotrexate 6Daunorubicin 6Mercaptopurine 5daratumumab 4Whole-Body Irradiation 4Vincristine 4Melphalan 4Idarubicin 4Etoposide 4Busulfan 4pembrolizumab 3obinutuzumab 3Radiotherapy 3Maintenance 3Immunotherapy, Adoptive 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Drug Therapy 3Cladribine 3Asparaginase 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasm, Residual × Clofarabine × Clear all
NCT03096782 2023-10-11

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
6 enrolled 10 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01158885 2021-10-26

Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia

Therapeutic Advances in Childhood Leukemia Consortium

Phase 2 Terminated
2 enrolled 7 charts
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡